492 related articles for article (PubMed ID: 31420042)
1. Wnt signaling: a promising target for osteoarthritis therapy.
Wang Y; Fan X; Xing L; Tian F
Cell Commun Signal; 2019 Aug; 17(1):97. PubMed ID: 31420042
[TBL] [Abstract][Full Text] [Related]
2. A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.
Deshmukh V; Hu H; Barroga C; Bossard C; Kc S; Dellamary L; Stewart J; Chiu K; Ibanez M; Pedraza M; Seo T; Do L; Cho S; Cahiwat J; Tam B; Tambiah JRS; Hood J; Lane NE; Yazici Y
Osteoarthritis Cartilage; 2018 Jan; 26(1):18-27. PubMed ID: 28888902
[TBL] [Abstract][Full Text] [Related]
3. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.
Yazici Y; McAlindon TE; Fleischmann R; Gibofsky A; Lane NE; Kivitz AJ; Skrepnik N; Armas E; Swearingen CJ; DiFrancesco A; Tambiah JRS; Hood J; Hochberg MC
Osteoarthritis Cartilage; 2017 Oct; 25(10):1598-1606. PubMed ID: 28711582
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.
Deshmukh V; O'Green AL; Bossard C; Seo T; Lamangan L; Ibanez M; Ghias A; Lai C; Do L; Cho S; Cahiwat J; Chiu K; Pedraza M; Anderson S; Harris R; Dellamary L; Kc S; Barroga C; Melchior B; Tam B; Kennedy S; Tambiah J; Hood J; Yazici Y
Osteoarthritis Cartilage; 2019 Sep; 27(9):1347-1360. PubMed ID: 31132406
[TBL] [Abstract][Full Text] [Related]
5. Lorecivivint, an intra-articular potential disease-modifying osteoarthritis drug.
Sabha M; Siaton BC; Hochberg MC
Expert Opin Investig Drugs; 2020 Dec; 29(12):1339-1346. PubMed ID: 33096010
[No Abstract] [Full Text] [Related]
6. Targeting
Iqbal Z; Xia J; Murtaza G; Shabbir M; Rehman K; Yujie L; Duan L
J Drug Target; 2023 Dec; 31(10):1027-1049. PubMed ID: 37969105
[TBL] [Abstract][Full Text] [Related]
7. To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy.
Blom AB; van Lent PL; van der Kraan PM; van den Berg WB
Curr Drug Targets; 2010 May; 11(5):620-9. PubMed ID: 20199388
[TBL] [Abstract][Full Text] [Related]
8. Intra-articular injection of a novel Wnt pathway inhibitor, SM04690, upregulates Wnt16 expression and reduces disease progression in temporomandibular joint osteoarthritis.
Hua B; Qiu J; Ye X; Liu X
Bone; 2022 May; 158():116372. PubMed ID: 35218985
[TBL] [Abstract][Full Text] [Related]
9. Artemisinin Ameliorates Osteoarthritis by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Zhong G; Liang R; Yao J; Li J; Jiang T; Liu J; Le Y; Shen C; Long H; Lu H; Ma S; Luo J; Miao Z; Su W; Zheng L; Zhao J
Cell Physiol Biochem; 2018; 51(6):2575-2590. PubMed ID: 30562742
[TBL] [Abstract][Full Text] [Related]
10. [The role of Wnt signaling pathway in osteoarthritis via the dual-targeted regulation of cartilage and subchondral bone].
Lian Q; Chi B; Zhang L; Tian F
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Jun; 34(6):797-803. PubMed ID: 32538575
[TBL] [Abstract][Full Text] [Related]
11. The Wnt signaling cascade in the pathogenesis of osteoarthritis and related promising treatment strategies.
Cheng J; Li M; Bai R
Front Physiol; 2022; 13():954454. PubMed ID: 36117702
[TBL] [Abstract][Full Text] [Related]
12. Potential role of nutraceuticals via targeting a Wnt/β-catenin and NF-κB pathway in treatment of osteoarthritis.
Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
J Food Biochem; 2022 Dec; 46(12):e14427. PubMed ID: 36165556
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin Signaling in Osteoarthritis and in Other Forms of Arthritis.
Zhou Y; Wang T; Hamilton JL; Chen D
Curr Rheumatol Rep; 2017 Sep; 19(9):53. PubMed ID: 28752488
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
Moroney MR; Woodruff E; Qamar L; Bradford AP; Wolsky R; Bitler BG; Corr BR
Mol Carcinog; 2021 Aug; 60(8):511-523. PubMed ID: 34038589
[TBL] [Abstract][Full Text] [Related]
15. Scutellarin ameliorates cartilage degeneration in osteoarthritis by inhibiting the Wnt/β-catenin and MAPK signaling pathways.
Liu F; Li L; Lu W; Ding Z; Huang W; Li YT; Cheng C; Shan WS; Xu J; He W; Zhanghui ; Yin Z
Int Immunopharmacol; 2020 Jan; 78():105954. PubMed ID: 31757676
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of the Wnt Signaling Pathway and Synovial Stem Cell Dysfunction in Osteoarthritis Development.
Huang J; Chen C; Liang C; Luo P; Xia G; Zhang L; Wang X; Wen Z; Cao X; Wu S
Stem Cells Dev; 2020 Apr; 29(7):401-413. PubMed ID: 31964233
[TBL] [Abstract][Full Text] [Related]
17. The Role of Wnt Pathway in the Pathogenesis of OA and Its Potential Therapeutic Implications in the Field of Regenerative Medicine.
De Santis M; Di Matteo B; Chisari E; Cincinelli G; Angele P; Lattermann C; Filardo G; Vitale ND; Selmi C; Kon E
Biomed Res Int; 2018; 2018():7402947. PubMed ID: 30410938
[TBL] [Abstract][Full Text] [Related]
18. Targeting β-catenin dependent Wnt signaling via peptidomimetic inhibitors in murine chondrocytes and OA cartilage.
Held A; Glas A; Dietrich L; Bollmann M; Brandstädter K; Grossmann TN; Lohmann CH; Pap T; Bertrand J
Osteoarthritis Cartilage; 2018 Jun; 26(6):818-823. PubMed ID: 29559252
[TBL] [Abstract][Full Text] [Related]
19. Mianserin suppresses R-spondin 2-induced activation of Wnt/β-catenin signaling in chondrocytes and prevents cartilage degradation in a rat model of osteoarthritis.
Okura T; Ohkawara B; Takegami Y; Ito M; Masuda A; Seki T; Ishiguro N; Ohno K
Sci Rep; 2019 Feb; 9(1):2808. PubMed ID: 30808932
[TBL] [Abstract][Full Text] [Related]
20. Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.
Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Clauw D; Jones M; Bergfeld J; Swearingen CJ; DiFrancesco A; Simsek I; Tambiah J; Hochberg MC
Arthritis Rheumatol; 2020 Oct; 72(10):1694-1706. PubMed ID: 32432388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
